Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study

• Fatemah A. Sakr,
• Michel J. Grothe,
• Enrica Cavedo,
• Irina Jelistratova,
• Marie-Odile Habert,
• Martin Dyrba,
• Gabriel Gonzalez-Escamilla,
• Hugo Bertin,
• Maxime Locatelli,
• Stephane Lehericy,
• Stefan Teipel,
• Bruno Dubois,
• Harald Hampel,
• for the INSIGHT-preAD study group,
• the Alzheimer Precision Medicine Initiative (APMI)

Affiliations

Fatemah A. Sakr

Department of Psychosomatic Medicine, Clinical Dementia Research, Faculty of Medicine, Rostock University

Michel J. Grothe

German Center for Neurodegenerative Diseases (DZNE)

Enrica Cavedo

AXA Research Fund and Sorbonne University Chair

Irina Jelistratova

German Center for Neurodegenerative Diseases (DZNE)

Marie-Odile Habert

Sorbonne University, UPMC University Paris 06, CNRS, INSERM, Laboratoire d’Imagerie Biomédicale

Martin Dyrba

German Center for Neurodegenerative Diseases (DZNE)

Gabriel Gonzalez-Escamilla

Department of Neurology, University Medical Center of the Johannes-Gutenberg-University Mainz

Hugo Bertin

Multi-center Neuroimaging Platform

Maxime Locatelli

Sorbonne University, UPMC University Paris 06, CNRS, INSERM, Laboratoire d’Imagerie Biomédicale

Stephane Lehericy

Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225

Stefan Teipel

Department of Psychosomatic Medicine, Clinical Dementia Research, Faculty of Medicine, Rostock University

Bruno Dubois

Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital

Harald Hampel

AXA Research Fund and Sorbonne University Chair

for the INSIGHT-preAD study group

the Alzheimer Precision Medicine Initiative (APMI)